Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$256K Buy
959
+158
+20% +$39.4K 0.1% 192
2023
Q2
$210K Buy
+801
New +$186K 0.08% 247
2021
Q3
Sell
-1,300
Closed -$318K 124
2021
Q2
$318K Buy
1,300
+397
+44% +$97.7K 0.07% 230
2021
Q1
$212K Sell
903
-2,703
-75% -$645K 0.06% 265
2020
Q4
$905K Buy
3,606
+817
+29% +$188K 0.28% 91
2020
Q3
$719K Buy
+2,789
New +$691K 0.29% 84

Other funds holding AMGN

TRUADVICE's AMGN Position: Q3 2023 in Review

TRUADVICE increased its Amgen (AMGN) stake by 20% in Q3 2023, buying an estimated $39.4K and bringing the position to 959 shares worth $256K. The position accounts for 0.1% of the portfolio, ranked #192.

TRUADVICE first reported a position in AMGN in Q3 2020 and has held it in 6 quarters since. The position peaked at $905K in Q4 2020. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • TRUADVICE held 959 shares of Amgen worth $256K as of Q3 2023.
  • TRUADVICE bought 158 Amgen shares in Q3 2023, an estimated $39.4K.
  • Amgen made up 0.1% of TRUADVICE's portfolio in Q3 2023, its #192 holding.
  • TRUADVICE first reported a position in Amgen in Q3 2020 and has held it in 6 quarters since.
  • TRUADVICE's Amgen position peaked at $905K in Q4 2020.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.